Joe Gogain, PhD, is Director of Clinical Research and Development at SomaLogic, with over 17 years of experience in assay development and biomarker discovery. For the past eight years, he has worked extensively with collaborative partners leveraging the SomaScan™ Assay for biomarker and target discovery initiatives.

As the therapeutic lead for cardiometabolic diseases, Joe partners with global pharmaceutical companies to support clinical trial evaluations and translational research efforts. He brings a strong track record in in vitro diagnostic (IVD) product development under design control, along with hands-on experience navigating de novo 510(k) regulatory submissions.

Joe has also served as a study director for national clinical trials involving point-of-care diagnostic devices, further demonstrating his commitment to advancing clinical innovation and precision medicine.